Endocrine » Obesity

Treatment of Obesity

Fluoxetine is not approved for use in achieving weight loss, but it has been known to cause minimal weight loss as a side effect, which is sometimes exploited. Sibutramine is a centrally-acting appetite suppressant that inhibits reuptake of noradrenalin, serotonin, and dopamine. Orlistat: blocks the action of pancreatic lipase, reducing triglyceride digestion and, thus, absorption. Bariatric surgery involves reducing the size of the gastric reservoir, with or without a degree of associated malabsorption.. Success of surgical treatment must begin with realistic goals and progress through the best possible use of well-designed and tested operations.

In order to proceed further, you need to have an account on IDG.
Create a new account now

Registered users, you can login below to access this page.